KEGG   DRUG: Bictegravir, emtricitabine and tenofovir alafenamide
Entry
D11039            Mixture   Drug                                   
Name
Bictegravir, emtricitabine and tenofovir alafenamide;
Biktarvy (TN)
Product
BIKTARVY (A-S Medication Solutions), BIKTARVY (Gilead Sciences)
Component
(Bictegravir [DR:D10909] | Bictegravir sodium [DR:D10910]), Emtricitabine [DR:D01199], (Tenofovir alafenamide [DR:D10428] | Tenofovir alafenamide fumarate [DR:D10605])
Class
Antiviral
 DG03107  Anti-HIV agent
Remark
Therapeutic category: 6250
ATC code: J05AR20
Product: D11039<JP/US>
Efficacy
Antiviral
  Disease
HIV-1 infection [DS:H01563]
Target
HIV-1 reverse transcriptase [KO:K24802]
HIV-1 integrase [KO:K24803]
  Pathway
ko03230  Viral genome structure
ko03240  Viral replication
ko03250  Viral life cycle - HIV-1
Interaction
Brite
Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
 J ANTIINFECTIVES FOR SYSTEMIC USE
  J05 ANTIVIRALS FOR SYSTEMIC USE
   J05A DIRECT ACTING ANTIVIRALS
    J05AR Antivirals for treatment of HIV infections, combinations
     J05AR20 Emtricitabine, tenofovir alafenamide and bictegravir
      D11039  Bictegravir, emtricitabine and tenofovir alafenamide <JP/US>
USP drug classification [BR:br08302]
 Antivirals
  Anti-HIV Combinations
   Bictegravir/ Emtricitabine/ Tenofovir Alafenamide
    D11039  Bictegravir, emtricitabine and tenofovir alafenamide
Therapeutic category of drugs in Japan [BR:br08301]
 6  Agents against pathologic organisms and parasites
  62  Chemotherapeutics
   625  Antivirals
    6250  Antivirals
     D11039  Bictegravir, emtricitabine and tenofovir alafenamide
Drug groups [BR:br08330]
 Antiviral
  DG03107  Anti-HIV agent
   D11039  Bictegravir, emtricitabine and tenofovir alafenamide
Drug classes [BR:br08332]
 Antiviral
  DG03107  Anti-HIV agent
   D11039  Bictegravir, emtricitabine and tenofovir alafenamide
Antimicrobials [BR:br08307]
 Antivirals
  Genome replication inhibitor
   HIV integrase inhibitor
    D11039  Bictegravir, emtricitabine and tenofovir alafenamide <JP/US>
New drug approvals in the USA [br08319.html]
 New molecular entities and new therapeutic biological products
  D11039
New drug approvals in Europe [br08329.html]
 European public assessment reports (EPAR) authorised medicine
  D11039
New drug approvals in Japan [br08318.html]
 Drugs with new active ingredients
  D11039
New drug approvals in the USA, Europe and Japan [br08328.html]
 Approval dates by FDA, EMA and PMDA
  D11039
Other DBs
PubChem: 354339134

» Japanese version   » Back

  All links  
Chemical substance (1)   
   PubChem (1)   
All databases (1)   

Download RDF
DBGET integrated database retrieval system